It is to be hoped that our ongoing longitudinal follow-up study will shed more light on the potential impact of specific prodromal features on the actual risk of developing GBA1-related PD and, accordingly, to the selection of candidates for interventional therapies. Here, GBA1 is linked to Parkinson disease.